ReviewClinical hematology international2020

Predicting Immuno-Metabolic Complications After Allogeneic Hematopoietic Cell Transplant with the Cytokine Interleukin-33 (IL-33) and its Receptor Serum-Stimulation 2 (ST2).

Uttam K Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.